ProfileJobs

LeMaitre Vascular

HealthTechnologyhardwarehealthtechmedical devices
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. The company is listed on NASDAQ.
Revenue(Q1, 2017)
$24.1 M
Market capitalization(2017-08-17)
$681.3 M
Company Growth (employees)
Type
Public
HQ
Burlington, US
Founded
1983
Size (employees)
397 (est)+18%
Website
lemaitre.com
LeMaitre Vascular was founded in 1983 and is headquartered in Burlington, US

LeMaitre Vascular Office Locations

LeMaitre Vascular has offices in Burlington, Inzell, Chiyoda, Mississauga and in 4 other locations
Burlington, US (HQ)
63 Second Ave
North Melbourne, AU
36 Munster Terrace
San Giuliano Milanese, IT
86 Viale Leone Tolstoj
Madrid, ES
Plaza de España
Mississauga, CA
608 5915 Airport Rd
Inzell, DE
Otto-Volger-Str. 5 a/b 65843 Sulzbach/Ts
Show all (8)

LeMaitre Vascular Data and Metrics

LeMaitre Vascular Financial Metrics

LeMaitre Vascular's revenue was reported to be $24.1 m in Q1, 2017
USD

Revenue (Q1, 2017)

24.1 m

Gross profit (Q1, 2017)

17.4 m

Gross profit margin (Q1, 2017), %

72%

Net income (Q1, 2017)

3.2 m

EBIT (Q1, 2017)

4.2 m

Market capitalization (17-Aug-2017)

681.3 m

Cash (31-Mar-2017)

25.8 m
LeMaitre Vascular's current market capitalization is $681.3 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

64.5 m71.1 m78.4 m89.2 m

Revenue growth, %

10%10%14%

Cost of goods sold

19.4 m22.7 m24.2 m26.2 m

Gross profit

45.1 m48.4 m54.2 m62.9 m

Gross profit Margin, %

70%68%69%71%

Operating expense total

40.6 m42.1 m42.7 m46.6 m

EBIT

4.5 m6.3 m11.5 m16.3 m

EBIT margin, %

7%9%15%18%

Interest expense

12 k5 k5 k14 k

Interest income

4 k1 k13 k81 k

Pre tax profit

4.3 m6.3 m11.4 m16.2 m

Income tax expense

1.1 m2.4 m3.7 m5.7 m

Net Income

3.2 m3.9 m7.8 m10.6 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

18.2 m17.5 m18.9 m19.9 m19 m20.3 m22.4 m23.2 m24.1 m

Cost of goods sold

5.8 m5.5 m5.8 m6.8 m5.5 m5.9 m7 m6.2 m6.8 m

Gross profit

12.4 m12 m13.1 m13.1 m13.5 m14.4 m15.4 m17 m17.4 m

Gross profit Margin, %

68%69%69%66%71%71%69%73%72%

Sales and marketing expense

5.5 m5.1 m5.9 m5.5 m5.5 m6.3 m6.5 m6.5 m7 m

R&D expense

1.1 m1.1 m1.2 m1.3 m1.4 m1.4 m1.6 m1.5 m1.7 m

General and administrative expense

3.3 m3.8 m3.6 m3.3 m3.5 m3.3 m3.4 m3.6 m4.5 m

Operating expense total

10 m10 m10.6 m10.2 m10.4 m11.1 m11.6 m11.7 m13.2 m

EBIT

2 m1.9 m2.3 m2.8 m3.3 m3.3 m3.8 m5.3 m4.2 m

EBIT margin, %

11%11%12%14%17%16%17%23%17%

Interest expense

(6 k)(6 k)

Interest income

1 k4 k3 k15 k16 k24 k20 k

Pre tax profit

2 m1.9 m2.3 m2.8 m3.1 m3.3 m3.8 m5.3 m4.2 m

Income tax expense

728 k965 k957 k1.1 m1 m1.1 m1.2 m2.1 m1 m

Net Income

1.1 m2 m1.4 m3.1 m5.2 m2.2 m4.8 m8 m3.2 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

14.7 m18.7 m27.5 m24.3 m

Accounts Receivable

243.9 m

Inventories

3.2 m2.4 m3.6 m2 m

Current Assets

41.7 m48.6 m58.2 m59 m

PP&E

5.8 m6.9 m7 m8 m

Goodwill

15 m17.3 m17.8 m23.4 m

Total Assets

70.5 m81.5 m90.7 m101.9 m

Accounts Payable

1.2 m1.1 m1.4 m1.2 m

Current Liabilities

10.2 m10 m10.4 m10.5 m

Total Liabilities

14.4 m

Additional Paid-in Capital

65.4 m75.4 m82.1 m85.4 m

Retained Earnings

(667 k)3.2 m8.2 m15.3 m

Total Equity

56.6 m68.2 m77.9 m87.5 m

Financial Leverage

1.2 x1.2 x1.2 x1.2 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

23.5 m18.4 m17 m19.4 m23.6 m25.9 m29.3 m34.7 m25.8 m

Inventories

15 m16.9 m16.5 m15.8 m15.9 m17.9 m17 m17.4 m

Current Assets

53 m49.4 m47.8 m50.3 m54 m59.7 m62.4 m68.2 m62.5 m

PP&E

5.5 m7.2 m6.6 m6.6 m6.8 m7.4 m7.3 m7.5 m9.3 m

Goodwill

15 m17.4 m17.1 m17.9 m17.7 m18.2 m18.2 m18.2 m23.6 m

Total Assets

80.5 m83.5 m79.6 m83.2 m86.6 m93.4 m95.5 m101.3 m106.5 m

Accounts Payable

1 m1 m1.1 m1.3 m931 k1.8 m1.6 m1.1 m2.2 m

Current Liabilities

9 m12.6 m8.4 m9.2 m8.8 m10.2 m10.1 m12.1 m10.8 m

Additional Paid-in Capital

75.5 m75.5 m76 m77.1 m80.2 m82.6 m83.4 m84.8 m86.7 m

Retained Earnings

398 k1.3 m3.9 m5 m6.4 m9.5 m11.3 m13.6 m17.5 m

Total Equity

67.8 m67.1 m67.9 m70.4 m74.2 m80.6 m82.9 m86.7 m91.6 m

Financial Leverage

1.2 x1.2 x1.2 x1.2 x1.2 x1.2 x1.2 x1.2 x1.2 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

3.2 m3.9 m7.8 m10.6 m

Depreciation and Amortization

2.8 m3.3 m3.4 m3.6 m

Accounts Receivable

(1.2 m)(654 k)(1.9 m)(922 k)

Inventories

(2.2 m)(2.7 m)608 k

Accounts Payable

861 k(1.1 m)2.6 m(103 k)

Cash From Operating Activities

5.4 m5.5 m11.4 m16.9 m

Purchases of PP&E

(2.7 m)(1.2 m)(2.3 m)(2.8 m)

Cash From Investing Activities

(6.2 m)(7.7 m)(3.5 m)(17.2 m)

Long-term Borrowings

(1.1 m)(1.1 m)(1.1 m)

Cash From Financing Activities

(961 k)6.7 m1.1 m(2.6 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

1.1 m2 m1.4 m3.1 m5.2 m2.2 m4.8 m8 m3.2 m

Depreciation and Amortization

1.6 m2.4 m832 k1.7 m2.5 m881 k1.8 m2.7 m979 k

Accounts Receivable

(813 k)(194 k)(1.7 m)(1.8 m)(1.1 m)(825 k)(776 k)(68 k)(858 k)

Inventories

(2.1 m)(2.5 m)(395 k)351 k(33 k)(392 k)264 k(216 k)(1.1 m)

Accounts Payable

(1.2 m)(304 k)(1.1 m)(418 k)214 k(1.8 m)(882 k)1.2 m(367 k)

Cash From Operating Activities

(66 k)2.8 m(600 k)3.3 m7.5 m1.3 m6.4 m12.7 m2.5 m

Purchases of PP&E

(549 k)(774 k)(323 k)(793 k)(1.6 m)(720 k)(1.7 m)

Cash From Investing Activities

(749 k)(6.4 m)(461 k)(2 m)(2.6 m)(3.1 m)(3.6 m)(4.2 m)(1.7 m)

Long-term Borrowings

(1.1 m)(1.1 m)

Cash From Financing Activities

9.6 m7.5 m(381 k)(353 k)232 k141 k(1 m)(1.5 m)559 k
USDY, 2017

Revenue/Employee

71.2 k

Financial Leverage

1.2 x

LeMaitre Vascular Market Value History

Market Position of LeMaitre Vascular

Competitors

TearLab
Health - Public
ReWalk Robotics Ltd
Technology - Public
Nuvectra Corporation
Technology - Public
iHear Medical
Technology - Private
Compare competitors

Traffic Overview of LeMaitre Vascular

LeMaitre Vascular Online and Social Media Presence

LeMaitre Vascular Company Life and Culture

You may also be interested in